✦ LIBER ✦

Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia

✍ Scribed by Tin Han; Ediz Z. Ezdinli; Katsutaro Shimaoka; Dinesh V. Desai

Publisher: John Wiley and Sons
Year: 1973
Tongue: English
Weight: 511 KB
Volume: 31
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197303)31:3<502::aid-cncr2820310303>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of chlorambucil and streptoni

Comparison of chlorambucil and streptonigrin (NSC-45383) in the treatment of chronic lymphocytic leukemia

✍ Dr. David T. Kaung; Richard M. Whittington; Herbert H. Spencer; Mary E. Patno 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 2 views

A pilot study of epirubicin and chloramb

A pilot study of epirubicin and chlorambucil in the treatment of chronic lymphocytic leukemia (CLL)

✍ Dr G. M. Smith; J. A. Child; D. W. Milligan; M. A. McEvoy; J. A. Murray 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

In a pilot study of the combination of epirubicin and chlorambucil in the treatment of chronic lymphocytic leukemia (CLL), 10 patients with advanced or progressive disease were treated in four centres. Up to a total of 15 courses in individual patients were given. Toxicity was relatively mild with n

Therapy program for patients with advanc

Therapy program for patients with advanced stages of chronic lymphocytic leukemia. Chlorambucil, splenectomy, and total lymph node irradiation

✍ Brigitte Pegourie-Bandelier; Jean-Jacques Sotto; Daniel Hollard; Michel Bolla; R 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB

Background. The clinical course of chronic lymphocytic leukemia (CLL) is variable. Staging systems define high risk groups, such as patients with Rai's Stage I11 and LV and Binet's stage C disease, as having a poor overall median survival. Most combination therapy programs have resulted in similar r

Acute lymphoblastic leukemia supervening

Acute lymphoblastic leukemia supervening in a case of chronic lymphocytic leukemia after continuous 3-year treatment with chlorambucil

✍ Dr. Sandro Eridani; Hugh Parry; Ursula Glass; Mel Greaves 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

Combined use of α2B-interferon, chloramb

Combined use of α2B-interferon, chlorambucil, and prednisone in the treatment of previously treated B-chronic lymphocytic leukemia patients

✍ Stefano Molica 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

Treatment of chronic lymphocytic leukemi

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone

✍ Emilio Montserrat; Antonio Alcalá; Ricardo Parody; Andreu Domingo; Javier García 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Ninety-six patients with advanced chronic lymphocytic leukemia (CLL) (Stage C; anemia and/or thrombocytopenia of nonimmune origin) were randomized to receive either chlorambucil (CLR) (0.4 mg/kg orally, day 6) plus prednime (PDN) (60 mg/m2 orally, days 1-5) every 2 weeks or cyclophosphamide (600 mg/